An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors
NCT00030043 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2015-03-25
Summary
This is a study to gather some information on the safety and efficacy of the penetrating auditory brainstem implant (PABI) in patients with neurofibromatosis type 2.
Conditions
- Neurofibromatosis 2
Interventions
- DEVICE
-
Penetrating auditory brainstem implant
Sponsors & Collaborators
-
FDA Office of Orphan Products Development
lead FED
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-09-30
- Completion
- 2003-08-31
Countries
- United States
Study Locations
More Related Trials
-
Natural History Study of Patients With Neurofibromatosis Type 2
NCT00598351 ·Status: RECRUITING
-
Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
NCT01129687 ·Status: COMPLETED
-
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
NCT05685836 ·Status: RECRUITING
-
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
NCT02211768 ·Status: COMPLETED ·Phase: PHASE1
-
Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
NCT02104323 ·Status: COMPLETED ·Phase: PHASE2
-
Tumor Treating Fields for the Treatment of Brainstem Gliomas
NCT05310448 ·Status: RECRUITING ·Phase: NA
-
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
NCT00899834 ·Status: COMPLETED
-
MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
NCT00147056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
NF2 Natural History Consortium
NCT00004483 ·Status: UNKNOWN
-
Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1
NCT05238909 ·Status: ENROLLING_BY_INVITATION
-
Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors
NCT00004659 ·Status: UNKNOWN ·Phase: PHASE2
-
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
NCT00060008 ·Status: TERMINATED ·Phase: NA
-
Study of Plexiform Neurofibromas in Neurofibromatosis Type 1
NCT00006435 ·Status: COMPLETED
-
PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)
NCT01800032 ·Status: COMPLETED
-
Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients
NCT05964153 ·Status: UNKNOWN ·Phase: NA
-
A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I
NCT04461886 ·Status: TERMINATED ·Phase: PHASE3
-
A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas
NCT04745156 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
In Vivo Confocal Endomicroscopy of the Brain
NCT00949793 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Facial Nerve in MRI 3T in the Preoperative Assessment of Parotid Tumors
NCT04104802 ·Status: WITHDRAWN
-
Using X-Ray Dye to Locate Hidden Parathyroid Tumors
NCT00001394 ·Status: COMPLETED
-
Intra-parotid Facial Nerve Tractography
NCT03950323 ·Status: UNKNOWN ·Phase: NA
-
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
NCT03820778 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study for Cerebral Open Flow Microperfusion
NCT07089758 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
WBSI Guided Personalized Delivery of TTFields
NCT05086497 ·Status: RECRUITING ·Phase: NA
-
Focused Ultrasound (FUS) Mesencephalotomy for Head & Neck Cancer Pain
NCT03894553 ·Status: COMPLETED ·Phase: NA